Healthcare
The healthcare sector remains one of the fastest growing parts of the global economy and one of the biggest challenges facing policy makers and the private sector. The cost of healthcare continues to outpace inflation in virtually every country in the world, and efforts at reform and cost containment make operating a commercial venture in the sector a continually dynamic enterprise. Despite the challenges, though, the sector holds great opportunities driven by the aging population in developed countries, increasing demand for sophisticated therapies and care systems in developing countries, rapidly advancing health technologies.
The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
Page 3/13
Microbix Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ImmunoGen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Senesco Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Alexza Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BioLineRx, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Omeros Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Corcept Therapeutics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Medicago, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Zogenix, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
HCA Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Oculus Innovative Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Celera Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Apotex, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
RTI Biologics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Entelos, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ImmunoVaccine, Inc. (formerly Rhino Resources, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Rigel Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Cell Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Regulus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Wockhardt Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Exiqon A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
OctoPlus N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Talecris Biotherapeutics Holdings Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Compugen, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
OncoMed Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Sangamo BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Eurand N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
NxStage Medical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Radius Health, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Cellular Dynamics International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Vical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Oragenics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Siemens Healthcare Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
SAIC-Frederick, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ChemDiv, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Glenmark Generics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Takeda Pharmaceuticals North America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ImmuneRegen BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Immunomedics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Ipsogen SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BioGaia AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options